Disclosure of voting rights for Chairman of the Board
24 Maio 2023 - 5:43AM
Disclosure of voting rights for Chairman of the Board
Oslo, 24 May 2023. PCI Biotech Holding ASA ("PCI
Biotech" or the "Company") issue this notification on behalf of its
chairman, Hans Peter Bøhn.
Hans Peter Bøhn is chairman of PCI Biotech and
shall open the annual general meeting of the Company on 25 May
2023. Mr. Bøhn holds 123,662 shares, representing 0.3 per cent of
the share capital of PCI Biotech. Mr. Bøhn has received powers of
attorney to represent and vote for 5,590,554 additional shares. In
total, Mr. Bøhn will represent and vote for 15.3 per cent of the
share capital. A major part of the powers of attorney are without
voting instructions. The powers of attorney are only valid at the
annual general meeting on 25 May 2023.
This information is subject to the disclosure
requirements pursuant to section 4 -3, cf. section 5-12 of the
Norwegian Securities Trading Act.
Contact
information: PCI
Biotech Holding ASA, Ullernchausséen 64, N-0379
Oslo Ronny
Skuggedal, CFO, rs@pcibiotech.no, Mobile: +47 9400 5757
Pci Biotech Holding Asa (LSE:0JGL)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Pci Biotech Holding Asa (LSE:0JGL)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
